Are you Dr. Sims?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 52 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
840 S Wood St
Ste 416
Chicago, IL 60612Phone+1 312-413-7707Fax+1 312-355-1497
Summary
- Dr. Thomas Sims Jr., MD is a general surgeon in Chicago, Illinois. He is currently licensed to practice medicine in Illinois, Indiana, and New Jersey. He is affiliated with University of Illinois Hospital, John H. Stroger Jr. Hospital of Cook County, and Sinai Medical Group.
Education & Training
- Oregon Health & Science University (OHSU Health)Fellowship, Pediatric Surgery, 2012 - 2014
- Nationwide Children's Hospital/Ohio State UniversityFellowship, Surgical Critical Care, 2010 - 2011
- University of TennesseeResidency, Surgery, 2003 - 2010
- Medical University of South CarolinaClass of 2003
Certifications & Licensure
- OR State Medical License 2013 - Present
- IL State Medical License 2018 - 2026
- OH State Medical License 2010 - 2026
- IN State Medical License 2019 - 2025
- FL State Medical License 2014 - 2024
- OK State Medical License 2018 - 2024
- PA State Medical License 2018 - 2024
- American Board of Surgery Surgery
- American Board of Surgery Pediatric Surgery
- American Board of Surgery Surgical Critical Care
- Join now to see all
Publications & Presentations
PubMed
- 124 citationsClinical predictors of leak after laparoscopic Roux-en-Y gastric bypass for morbid obesityElizabeth Costa Hamilton, Thomas Sims, T. T. Hamilton, Mary A. Mullican, Daniel B. Jones
Surgical Endoscopy. 2003-03-07 - 337 citationsBevacizumab-Induced Transient Remodeling of the Vasculature in Neuroblastoma Xenografts Results in Improved Delivery and Efficacy of Systemically Administered Chemothe...Paxton V. Dickson, John B. Hamner, Thomas L. Sims, Charles H. Fraga, Catherine Y.C. Ng
Clinical Cancer Research. 2007-07-01 - 16 citationsIFN-beta sensitizes neuroblastoma to the antitumor activity of temozolomide by modulating O6-methylguanine DNA methyltransferase expression.Shannon F. Rosati, Regan F. Williams, Lindsey C. Nunnally, Mackenzie McGee, Thomas L. Sims
Molecular Cancer Therapeutics. 2008-12-01